Works matching IS 00070920 AND DT 2024 AND VI 131 AND IP 3
Results: 21
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Correction: DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Editorial Expression of Concern: Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction to: Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 601, doi. 10.1038/s41416-024-02760-1
- By:
- Publication type:
- Article
Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 468, doi. 10.1038/s41416-024-02758-9
- By:
- Publication type:
- Article
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 515, doi. 10.1038/s41416-024-02756-x
- By:
- Publication type:
- Article
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage response.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 534, doi. 10.1038/s41416-024-02755-y
- By:
- Publication type:
- Article
DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 498, doi. 10.1038/s41416-024-02754-z
- By:
- Publication type:
- Article
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 524, doi. 10.1038/s41416-024-02746-z
- By:
- Publication type:
- Article
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 589, doi. 10.1038/s41416-024-02752-1
- By:
- Publication type:
- Article
Metastasis-associated fibroblasts in peritoneal surface malignancies.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 407, doi. 10.1038/s41416-024-02717-4
- By:
- Publication type:
- Article
CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 444, doi. 10.1038/s41416-024-02750-3
- By:
- Publication type:
- Article
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 577, doi. 10.1038/s41416-024-02749-w
- By:
- Publication type:
- Article
The in vitro dynamics of pseudo-vascular network formation.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 457, doi. 10.1038/s41416-024-02722-7
- By:
- Publication type:
- Article
Anti-PEc: Development of a novel monoclonal antibody against prostate cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 551, doi. 10.1038/s41416-024-02713-8
- By:
- Publication type:
- Article
Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 481, doi. 10.1038/s41416-024-02744-1
- By:
- Publication type:
- Article
Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 430, doi. 10.1038/s41416-024-02742-3
- By:
- Publication type:
- Article
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 565, doi. 10.1038/s41416-024-02731-6
- By:
- Publication type:
- Article
Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 491, doi. 10.1038/s41416-024-02728-1
- By:
- Publication type:
- Article
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 420, doi. 10.1038/s41416-024-02684-w
- By:
- Publication type:
- Article